These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3203706)

  • 1. Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers.
    De Lepeleire I; Van Hecken A; Verbesselt R; Kaiser G; Barner A; Holmes I; De Schepper PJ
    Eur J Clin Pharmacol; 1988; 34(5):465-8. PubMed ID: 3203706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The absence of a pharmacokinetic interaction between aspirin and the angiotensin-converting enzyme inhibitor benazepril in healthy volunteers.
    Sioufi A; Pommier F; Gauducheau N; Godbillon J; Choi L; John V
    Biopharm Drug Dispos; 1994 Aug; 15(6):451-61. PubMed ID: 7993983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of benazepril relative to other ACE inhibitors.
    Gengo FM; Brady E
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV44-50; discussion IV51-5. PubMed ID: 1893642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses.
    Serrano-Rodríguez JM; Gómez-Díez M; Esgueva M; Castejón-Riber C; Mena-Bravo A; Priego-Capote F; Ayala N; Caballero JMS; Muñoz A
    Res Vet Sci; 2017 Oct; 114():117-122. PubMed ID: 28371693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril.HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration.
    Kaiser G; Ackermann R; Brechbühler S; Dieterle W
    Biopharm Drug Dispos; 1989; 10(4):365-76. PubMed ID: 2758102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of benazepril, robenacoxib and their combination on glomerular filtration rate in cats.
    King JN; Panteri A; Graille M; Seewald W; Friton G; Desevaux C
    BMC Vet Res; 2016 Jun; 12(1):124. PubMed ID: 27338786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction study between benazepril and amlodipine in healthy subjects.
    Sun JX; Cipriano A; Chan K; John VA
    Eur J Clin Pharmacol; 1994; 47(3):285-9. PubMed ID: 7867683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of food on the bioavailability of CGS 16617, an angiotensin-converting enzyme inhibitor, in healthy subjects.
    Choi RL; Kochak GM; Reydel-Bax P; Nelson EB
    J Clin Pharmacol; 1988 Sep; 28(9):848-52. PubMed ID: 3230152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs.
    Lantis AC; Ames MK; Atkins CE; DeFrancesco TC; Keene BW; Werre SR
    J Vet Pharmacol Ther; 2015 Feb; 38(1):65-73. PubMed ID: 25224804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride.
    Kaiser G; Ackermann R; Gschwind HP; James IM; Sprengers D; McIntyre N; Defalco A; Holmes IB
    Biopharm Drug Dispos; 1990 Dec; 11(9):753-64. PubMed ID: 2271751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
    Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
    Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers.
    Schaller MD; Nussberger J; Waeber B; Bussien JP; Turini GA; Brunner H; Brunner HR
    Eur J Clin Pharmacol; 1985; 28(3):267-72. PubMed ID: 2988972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
    King JN; Mauron C; Kaiser G
    Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of benazepril and robenacoxib and their combination on glomerular filtration rate in dogs.
    Panteri A; Kukk A; Desevaux C; Seewald W; King JN
    J Vet Pharmacol Ther; 2017 Jan; 40(1):44-56. PubMed ID: 27302598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril.
    Jakobsen J; Glaus L; Graf P; Degen P; Maurice NP; Bellet M; Ménard J
    J Hypertens; 1992 Sep; 10(9):1045-51. PubMed ID: 1328364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of renal clearance of furosemide by pentopril, an angiotensin-converting enzyme inhibitor.
    Rakhit A; Kochak GM; Tipnis V; Hurley ME
    Clin Pharmacol Ther; 1987 May; 41(5):580-6. PubMed ID: 3032491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of lisinopril.
    Beermann B
    Am J Med; 1988 Sep; 85(3B):25-30. PubMed ID: 2844083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog.
    King JN; Maurer M; Morrison CA; Mauron C; Kaiser G
    Xenobiotica; 1997 Aug; 27(8):819-29. PubMed ID: 9293618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of benazepril hydrochloride in patients with major proteinuria.
    Schweizer C; Kaiser G; Dieterle W; Mann J
    Eur J Clin Pharmacol; 1993; 44(5):463-6. PubMed ID: 8359184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.
    Mochel JP; Fink M; Peyrou M; Soubret A; Giraudel JM; Danhof M
    Pharm Res; 2015 Jun; 32(6):1931-46. PubMed ID: 25446774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.